Alphanosos concludes a research partnership to explore plant-based solutions for neurodevelopmental disorders.

Alphanosos announces a new scientific research partnership with Professor Stéphane Bézieau’s team at the Thorax Institute (Inserm UMR 1087 / CNRS UMR 6291) in Nantes, France.

This collaboration aims to combine the power of Alphanosos’s proprietary artificial intelligence platform with the scientific expertise of Professor Bézieau’s team, in order to identify combinations of botanical extracts from edible plants capable of correcting cellular dysfunctions observed in certain models of neurodevelopmental disorders, specifically those related to the ubiquitin-proteasome system.

In the long term, this research seeks to explore the potential of safe solutions in the form of plant-based dietary supplements that could help manage or modulate some of these disorders.
By coupling cutting-edge biomedical research with Alphanosos’s innovative WECMEPTM technology (Water Extracts of Complex Mixes of Edible Plants), this partnership promises a bold step forward toward natural and accessible solutions in a field where unmet medical needs remain significant.

ALPHANOSOS
Biopôle Clermont-Limagne
Phone: +33 982 216 506
Email: contact@alphanosos.com
Website: www.alphanosos.com